These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7617282)

  • 1. Changing the regimen.
    Chapman JR
    Nephrol Dial Transplant; 1995; 10 Suppl 1():51-7. PubMed ID: 7617282
    [No Abstract]   [Full Text] [Related]  

  • 2. Withdrawal of steroids from a cyclosporine-based regimen: pro.
    Ponticelli C
    Transplant Proc; 1998 Aug; 30(5):1782-4. PubMed ID: 9723281
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive treatment options in renal transplantation.
    Ciancio G; Burke GW; Jorge D; Rosen A; Miller J
    Minerva Urol Nefrol; 2005 Sep; 57(3):141-9. PubMed ID: 15986013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.
    Abramowicz D; Del Carmen Rial M; Vitko S; del Castillo D; Manas D; Lao M; Gafner N; Wijngaard P;
    J Am Soc Nephrol; 2005 Jul; 16(7):2234-40. PubMed ID: 15917338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid immunosuppression in kidney transplantation: a passing era.
    Schulak JA
    J Surg Res; 2004 Mar; 117(1):154-62. PubMed ID: 15013726
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss.
    Isoniemi H; Kyllönen L; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Ahonen J
    Transplant Proc; 1995 Feb; 27(1):875-7. PubMed ID: 7879216
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.
    Goldfarb DA
    J Urol; 2015 Mar; 193(3):950. PubMed ID: 25765417
    [No Abstract]   [Full Text] [Related]  

  • 8. Balancing efficacy and toxicity in kidney-transplant immunosuppression.
    Leichtman AB
    N Engl J Med; 2007 Dec; 357(25):2625-7. PubMed ID: 18094383
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids.
    Offner G; Toenshoff B; Höcker B; Krauss M; Bulla M; Cochat P; Fehrenbach H; Fischer W; Foulard M; Hoppe B; Hoyer PF; Jungraithmayr TC; Klaus G; Latta K; Leichter H; Mihatsch MJ; Misselwitz J; Montoya C; Müller-Wiefel DE; Neuhaus TJ; Pape L; Querfeld U; Plank C; Schwarke D; Wygoda S; Zimmerhackl LB
    Transplantation; 2008 Nov; 86(9):1241-8. PubMed ID: 19005406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early steroid withdrawal protocol using basiliximab in kidney transplantation.
    Teraoka S; Sato S; Kai K; Kawase T; Nakamura M; Tojinbara T; Nakajima I; Fuchinoue S
    Transplant Proc; 2004 Mar; 36(2 Suppl):478S-482S. PubMed ID: 15041392
    [No Abstract]   [Full Text] [Related]  

  • 11. Steroid withdrawal from cyclosporine-based regimens: con--a flawed strategy.
    Hricik DE; Schulak JA
    Transplant Proc; 1998 Aug; 30(5):1785-7. PubMed ID: 9723282
    [No Abstract]   [Full Text] [Related]  

  • 12. Recovery of graft function in pediatric kidney transplantation is not affected by delayed introduction of cyclosporine.
    Cransberg K; Bouts AH; Cornelissen EA; Lilien MR; Van Hoeck KJ; Hop WC; Nauta J
    Transplantation; 2008 Nov; 86(9):1199-205. PubMed ID: 19005400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New immunosuppressive agents: a way to get rid of corticosteroids?
    Morelon E; Kreis H
    Transplantation; 2000 Nov; 70(9):1271-2. PubMed ID: 11087138
    [No Abstract]   [Full Text] [Related]  

  • 14. Steroid avoidance or withdrawal after kidney transplantation: a balancing act.
    Sprangers B; Vanrenterghem Y
    Transplantation; 2010 Aug; 90(4):350-2. PubMed ID: 20548264
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive therapy without calcineurin inhibitors for renal transplants? Perhaps we should be cautions...].
    Fasoli G
    G Ital Nefrol; 2007; 24(2):110. PubMed ID: 17458825
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of anti CD45 on different immunosuppressive regimes in renal transplantation.
    Talbot D; Shenton BK; Bell A; White M; Glennon A; Manas D; Minford E; Rix D; Mathew A; Kumar A; Taylor RM
    Transplant Proc; 1996 Dec; 28(6):3212-3. PubMed ID: 8999605
    [No Abstract]   [Full Text] [Related]  

  • 17. Strategies to reduce or replace steroid dosing.
    Vanrenterghem Y
    Transplant Proc; 1999 Dec; 31(8A):7S-10S. PubMed ID: 10616554
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative study of clinical outcome in kidney transplantation between early steroid withdrawal protocol using basiliximab, calcineurin inhibitor, and mycophenolate mofetil and triple regimen consisting of calcineurin inhibitor, mycophenolate mofetil, and steroid.
    Teraoka S; Sato S; Sekijima M; Iwado K; Urashima Y; Kudo S; Kai K; Koyama I; Tojinbara T; Nakajima I; Fuchinoue S
    Transplant Proc; 2005 Mar; 37(2):791-4. PubMed ID: 15848533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient management by cyclosporine C2 monitoring.
    Jorga A; Johnston A; Holt DW
    Transplantation; 2004 Jan; 77(2):323-4. PubMed ID: 14743006
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with cyclosporine.
    Langone AJ; Helderman JH
    Transplant Proc; 2004 Mar; 36(2 Suppl):59S-63S. PubMed ID: 15041308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.